AP News

News Summary: Sanofi profit slumps in 3rd quarter


SHRINKING PROFIT: Sanofi saw its earnings slump in the third quarter as generic competitors ate into profits of its Eloxatin cancer treatment.

DETAILS: Sanofi earned €1.6 billion ($2.1 billion) for the July-September quarter, down 20 percent from €2 billion a year earlier. Sanofi lost €448 million in sales from generic competition in the quarter, although overall sales rose 3.3 percent to €9 billion.

LOOKING AHEAD: The French drugmaker now expects its core earnings to fall 12 percent this year compared to 2011, at constant exchange rates.


Burger King's Young Buns
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus